greeksoup/ stocks
Stocks / United States / JNJ / Q4 FY2024

Johnson & Johnson Q4 FY2024 results: revenue $22.5 billion, up 5.3% on the year

Johnson & Johnson (JNJ) reported revenue of $22.5 billion for Q4 FY2024, the quarter ended 29 December 2024, up 5.3% on the same quarter a year earlier. Net income was $3.4 billion, down 15.3% on the year, and diluted earnings per share $1.41. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2025.

Revenue$22.5 billionup 5.3%
Net income$3.4 billiondown 15.3%
Diluted EPS$1.41
QuarterQ4 FY2024ended 29 December 2024

The quarter, against the one before and a year earlier

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Revenue22,52022,47121,395+5.3%
Cost of revenue7,1286,9633,340+113.4%
Gross profit15,39215,50814,597+5.4%
Gross margin68.3%69.0%68.2%
Research and development5,2984,9524,246+24.8%
Selling, general and administrative6,4535,4783,309+95.0%
Interest expense13719319.0+621.1%
Pre-tax income3,8873,3384,826-19.5%
Income tax456644-121n/a
Effective tax rate11.7%19.3%-2.5%
Net income3,4312,6944,049-15.3%
Net margin15.2%12.0%18.9%
Diluted EPS$1.41$1.11$1.67-15.6%

$ million except per share. Fourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Operating cash flow6,9837,9937,863-11.2%
Capital expenditure1,6121,0291,589+1.4%
Free cash flow5,3716,9646,274-14.4%
Free cash flow margin23.8%31.0%29.3%
Depreciation and amortisation1,8961,8461,843+2.9%
Share-based compensation238295178+33.7%
Buybacks282539216+30.6%
Dividend per sharen/a$1.24n/an/a
Diluted shares, weighted2,429m2,428mn/an/a
Shares outstanding at period end2,408m2,408m2,409m-0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2024Q3 FY2024Q4 FY2023Change on the year
Total assets180,104178,287167,558+7.5%
Cash and equivalents24,10519,98021,859+10.3%
Receivables14,84216,17414,873-0.2%
Inventory12,44412,60311,181+11.3%
Goodwill44,20044,79936,558+20.9%
Long-term debt32,40031,28927,350+18.5%
Shareholders' equity71,49070,15868,774+3.9%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue21,35121,39521,38322,44722,47122,52021,89323,74323,99324,56424,06225,310
Cost of revenue6,6063,3406,5116,8696,9637,1287,3577,6287,3037,9688,1068,051
Gross profit14,74514,59714,87215,57815,50815,39214,53616,11516,69016,59615,95617,259
Gross margin69%68%70%69%69%68%66%68%70%68%66%68%
R&D3,4474,2463,5423,4404,9525,2983,2253,5163,6724,2523,5273,653
SG&A5,4003,3095,2575,6815,4786,4535,1125,8895,9226,7536,0346,432
Interest expense19219.0155270193137204308245214272281
Pre-tax income5,2174,8263,7145,7483,3383,88713,6316,4917,4934,9665,9906,747
Tax rate17%-3%12%18%19%12%19%15%31%-3%13%18%
Net income26,0284,0493,2554,6862,6943,43110,9995,5375,1525,1165,2355,534
Net margin122%19%15%21%12%15%50%23%21%21%22%22%
Diluted EPS$10.21$1.67$1.34$1.93$1.11$1.41$4.54$2.29$2.12$2.08$2.14$2.27
Operating cash flow7,4897,8633,6575,6337,9936,9834,1743,8789,1697,3092,5148,616
Capital expenditure9671,5898079761,0291,6127951,0431,1571,8371,0491,321
Free cash flow6,5226,2742,8504,6576,9645,3713,3792,8358,0125,4721,4657,295
Buybacks9202161,4751365392822,1270.01,9021,9244,028221
Shares outstanding2,407m2,409m2,407m2,407m2,408m2,408m2,406m2,408m2,409m2,410m2,407m2,410m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 29 December 2024, filed 13 February 2025, accession 0000200406-25-000038: the filing on EDGAR. All of Johnson & Johnson's filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install